Sanjay Merchant

1.3k total citations
53 papers, 945 citations indexed

About

Sanjay Merchant is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Sanjay Merchant has authored 53 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 12 papers in Applied Microbiology and Biotechnology and 11 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Sanjay Merchant's work include Antibiotic Use and Resistance (12 papers), Nosocomial Infections in ICU (11 papers) and Pneumonia and Respiratory Infections (9 papers). Sanjay Merchant is often cited by papers focused on Antibiotic Use and Resistance (12 papers), Nosocomial Infections in ICU (11 papers) and Pneumonia and Respiratory Infections (9 papers). Sanjay Merchant collaborates with scholars based in United States, United Kingdom and Belgium. Sanjay Merchant's co-authors include Laura Puzniak, Esther E Avendano, Gowri Raman, Jeffrey Chan, C. Daniel Mullins, Kasem S. Akhras, Margaret Rothman, François Giuliano, Giuseppe Pera and Elena Polverejan and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and Journal of the American Society of Nephrology.

In The Last Decade

Sanjay Merchant

48 papers receiving 911 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanjay Merchant United States 16 282 218 184 181 179 53 945
Elena Graziano Italy 14 329 1.2× 164 0.8× 279 1.5× 40 0.2× 144 0.8× 37 1.0k
İ̇lker İnanç Balkan Türkiye 19 202 0.7× 79 0.4× 265 1.4× 35 0.2× 110 0.6× 81 1.1k
Edoardo Pozzi Italy 19 56 0.2× 101 0.5× 128 0.7× 208 1.1× 65 0.4× 122 1.4k
Christian Eckmann Germany 11 330 1.2× 221 1.0× 242 1.3× 18 0.1× 273 1.5× 23 925
Kavita K. Trivedi United States 15 61 0.2× 244 1.1× 155 0.8× 57 0.3× 55 0.3× 32 689
Marco Mantero Italy 18 83 0.3× 56 0.3× 496 2.7× 36 0.2× 48 0.3× 63 1.2k
Kieran Hand United Kingdom 15 132 0.5× 319 1.5× 222 1.2× 77 0.4× 103 0.6× 48 806
G Bouvenot France 14 112 0.4× 263 1.2× 347 1.9× 35 0.2× 272 1.5× 103 1.3k
Caitlyn T. Solem United States 20 27 0.1× 117 0.5× 240 1.3× 34 0.2× 94 0.5× 70 1.1k
Cenk Aypak Türkiye 15 79 0.3× 64 0.3× 247 1.3× 36 0.2× 37 0.2× 76 794

Countries citing papers authored by Sanjay Merchant

Since Specialization
Citations

This map shows the geographic impact of Sanjay Merchant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjay Merchant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjay Merchant more than expected).

Fields of papers citing papers by Sanjay Merchant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjay Merchant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjay Merchant. The network helps show where Sanjay Merchant may publish in the future.

Co-authorship network of co-authors of Sanjay Merchant

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjay Merchant. A scholar is included among the top collaborators of Sanjay Merchant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjay Merchant. Sanjay Merchant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ponce‐de‐León, Alfredo, Sanjay Merchant, Gowri Raman, et al.. (2020). Pseudomonas infections among hospitalized adults in Latin America: a systematic review and meta-analysis. BMC Infectious Diseases. 20(1). 250–250. 15 indexed citations
4.
Raman, Gowri, Esther E Avendano, Jeffrey Chan, Sanjay Merchant, & Laura Puzniak. (2018). Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrobial Resistance and Infection Control. 7(1). 79–79. 175 indexed citations
5.
Merchant, Sanjay, David Provenzano, Samir H. Mody, Kai Fai Ho, & Mila Etropolski. (2013). Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: Pooled analysis of randomized studies. Journal of Opioid Management. 9(1). 51–61. 9 indexed citations
6.
Ivanova, Jasmina, et al.. (2013). The prevalence and economic impact of prescription opioid-related side effects among patients with chronic noncancer pain. Journal of Opioid Management. 9(4). 239–254. 20 indexed citations
7.
Merchant, Sanjay, et al.. (2013). Budget Impact Analysis of Tapentadol Extended Release for the Treatment of Moderate to Severe Chronic Noncancer Pain. Clinical Therapeutics. 35(5). 659–672. 12 indexed citations
8.
Neil, Nancy, et al.. (2012). Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States. Journal of Medical Economics. 16(2). 307–317. 9 indexed citations
9.
Nalysnyk, Luba, et al.. (2011). PSY1 Tolerability of Oral Long-Acting Opioids in the Treatment of Chronic Pain: a Systematic Literature Review and Meta-Analysis. Value in Health. 14(7). A410–A410. 2 indexed citations
10.
Itani, Kamal M.F., et al.. (2010). Outcomes and management costs in patients hospitalized for skin and skin-structure infections. American Journal of Infection Control. 39(1). 42–49. 41 indexed citations
11.
Kollef, Marin H., Dilip Nathwani, Sanjay Merchant, et al.. (2010). Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators. Critical Care. 14(3). R84–R84. 10 indexed citations
12.
Kollef, Marin H., Dilip Nathwani, Sanjay Merchant, et al.. (2009). MEDICAL RESOURCE UTILIZATION AMONG PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA: POOLED ANALYSIS OF RANDOMIZED STUDIES OF DORIPENEM VERSUS COMPARATORS. CHEST Journal. 136(4). 30S–30S. 1 indexed citations
13.
Itani, Kamal M.F., et al.. (2009). Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections. PharmacoEconomics. 27(5). 421–430. 12 indexed citations
14.
Merchant, Sanjay. (2008). Impact of Nosocomial Transmission of Pseudomonas aeruginosa on Cost-Effectiveness of Doripenem versus Imipenem in Treatment of Ventilator-Associated Pneumonia. 46th Annual Meeting. 2 indexed citations
15.
Merchant, Sanjay, Chris Gast, Dilip Nathwani, et al.. (2008). Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia. Clinical Therapeutics. 30(4). 717–733. 34 indexed citations
16.
Giuliano, François, Donald L. Patrick, Hartmut Porst, et al.. (2007). Premature Ejaculation: Results from a Five-Country European Observational Study. European Urology. 53(5). 1048–1057. 143 indexed citations
17.
Hellmich, Martin, Thomas Evers, Maria Kubin, et al.. (2005). Development and Validation of a Risk Score for Somatic Erectile Dysfunction: Combined Results from Three Cross-Sectional Surveys. European Urology. 48(3). 495–502. 5 indexed citations
18.
Keating, Karen, et al.. (2004). Acute Uncomplicated UTI and E. coli Resistance: Implications for First-Line Empirical Antibiotic Therapy. Journal of Managed Care Pharmacy. 10(1). 17–25. 18 indexed citations
19.
Merchant, Sanjay, C. Daniel Mullins, & Ya‐Chen Tina Shih. (2003). Factors associated with hospitalization costs for patients with community acquired pneumonia. Clinical Therapeutics. 25(2). 593–610. 21 indexed citations
20.
Thomas, Simu K., Sandra E. Brooks, C. Daniel Mullins, Claudia R. Baquet, & Sanjay Merchant. (2002). Use of ICD‐9 coding as a proxy for stage of disease in lung cancer. Pharmacoepidemiology and Drug Safety. 11(8). 709–713. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Graziano Breakdown of academic impact, for papers by İ̇lker İnanç Balkan Breakdown of academic impact, for papers by Edoardo Pozzi Breakdown of academic impact, for papers by Christian Eckmann Breakdown of academic impact, for papers by Kavita K. Trivedi Breakdown of academic impact, for papers by Marco Mantero Breakdown of academic impact, for papers by Kieran Hand Breakdown of academic impact, for papers by G Bouvenot Breakdown of academic impact, for papers by Caitlyn T. Solem Breakdown of academic impact, for papers by Cenk Aypak
Rankless by CCL
2026